Oxford Nanopore Technologies PLC (ONT)

Industry Biotechnology


This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

125.80p

Buy

126.40p

arrow-down-0.50p (-0.39%)

Prices updated at 19 Dec 2025, 16:35 GMT
| Prices minimum 15 mins delay
|
Prices in GBX

Income statement

20232024
170m183m
90m105m
-169m-152m
-99.38-83.16
-155m-146m
-106m-93m
Sales, General and administrative155m159m
Interest expenses2m4m
Provision for income taxes5m6m
Operating expenses259m258m
Income before taxes-150m-140m
Net income available to common shareholders-155m-146m
-0.19-0.16
Net interest income17m11m
Advertising and promotion--
Net investment income, net153,0002m
Realised capital gains (losses), net--
Total benefits, claims and expenses--
Earnings per share (diluted)-0.19-0.16
Free cash flow per share-0.1843-0.1991
Book value/share0.74630.6058
Debt equity ratio0.0579840.069254

Balance sheet

20232024
Current assets447m520m
Current liabilities89m111m
Total capital644m586m
Total debt42m46m
Total equity644m586m
Total non current liabilities--
Loans--
Total assets777m742m
Total liabilities--
Cash and cash equivalents221m200m
Common stock859m955m

Cash flow

20232024
Cash at beginning of period357m221m
Cash dividends paid--
-165m-159m
Investments (gains) losses-62m15m
221m200m
Net income--
-137m-110m
-27m-49m
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.